河北医学
河北醫學
하북의학
HEBEI MEDICINE
2001年
4期
321-323
,共3页
宋晓华%盖延红%许颖川
宋曉華%蓋延紅%許穎川
송효화%개연홍%허영천
头孢克罗%泌尿系感染
頭孢剋囉%泌尿繫感染
두포극라%비뇨계감염
目的:观察新达罗(国产头孢克罗)治疗泌尿系感染的疗效,并与希刻劳(进口头孢克罗)进行比较。方法:95例泌尿系感染患者随机分为A组(50例)和B组(45例)。A组用新达罗胶囊0.25~0.5g/次,tid,疗程7~14d,B组用希刻劳胶囊0.25~0.5g/次,tid,疗程7~14d。结果:A、B两组临床有效率分别为90%和91.1%(P>0.05),细菌清除率分别为87.8%和89.2%(P>0.05),两者之间无显著性差异,且不良反应轻微。结论:国产与进口头孢克罗治疗泌尿系感染同样疗效显著,不良反应少。
目的:觀察新達囉(國產頭孢剋囉)治療泌尿繫感染的療效,併與希刻勞(進口頭孢剋囉)進行比較。方法:95例泌尿繫感染患者隨機分為A組(50例)和B組(45例)。A組用新達囉膠囊0.25~0.5g/次,tid,療程7~14d,B組用希刻勞膠囊0.25~0.5g/次,tid,療程7~14d。結果:A、B兩組臨床有效率分彆為90%和91.1%(P>0.05),細菌清除率分彆為87.8%和89.2%(P>0.05),兩者之間無顯著性差異,且不良反應輕微。結論:國產與進口頭孢剋囉治療泌尿繫感染同樣療效顯著,不良反應少。
목적:관찰신체라(국산두포극라)치료비뇨계감염적료효,병여희각로(진구두포극라)진행비교。방법:95례비뇨계감염환자수궤분위A조(50례)화B조(45례)。A조용신체라효낭0.25~0.5g/차,tid,료정7~14d,B조용희각로효낭0.25~0.5g/차,tid,료정7~14d。결과:A、B량조림상유효솔분별위90%화91.1%(P>0.05),세균청제솔분별위87.8%화89.2%(P>0.05),량자지간무현저성차이,차불량반응경미。결론:국산여진구두포극라치료비뇨계감염동양료효현저,불량반응소。
Objective:To observe the efficacy of domestic and imported cefaclor in treating urinary infections.Methods:95 patients with urinary infections were randomly divided to group a and groupB,The And B receive 0.25~0.5g dose of domestic or imported cefaclor three times daily for 7~14 days in both.Results:The effective rate for domestic and imported cefaclor ams were 90% and 91.1% respectively(P>0.05)and the bacterial eradication rate for domestic and imported cefaclor were 87.8% and 89.2% respectively(P>0.05).No significant difference exists between the two arms with mild ARDs.Conclusion:Domestic cefaclor is as effective as imported one in treatment urinary infections with mild ARDs.